Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from Australia.
Peleg
Anton Y
AY
Franklin
Clare
C
Bell
Jan
J
Spelman
Denis W
DW
D000293:Adolescent; D001315:Australia; D001426:Bacterial Proteins / Q000378:metabolism; D002051:Burkitt Lymphoma / Q000150:complications; D015780:Carbapenems / Q000494:pharmacology*; D005260:Female; D006801:Humans; D011552:Pseudomonas Infections / Q000209:etiology / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology; D001618:beta-Lactamases / Q000378:metabolism*
D001426:Bacterial Proteins; D015780:Carbapenems; C425142:beta-lactamase IMP-4; D001618:beta-Lactamases; C063912:carbapenemase